James P. Shaughnessy, the Chief Legal Officer at DocuSign, Inc. (NASDAQ:DOCU), has recently sold shares valued at approximately $676,311. According to a recent SEC filing, Shaughnessy disposed of 7,500 shares of common stock in transactions executed on January 2, 2025. The shares were sold at prices ranging from $90.13 to $90.53. The transaction comes as DocuSign, currently valued at $18.2 billion, trades near its InvestingPro Fair Value with impressive gross profit margins of 80%.
Following these transactions, Shaughnessy retains ownership of 43,781 shares in the company. The sales were conducted under a pre-arranged 10b5-1 trading plan, which allows company insiders to sell a predetermined number of shares at a set time to avoid potential accusations of insider trading. Despite this insider sale, InvestingPro data shows management has been actively buying back shares, with the stock delivering an impressive 66% return over the past six months. For deeper insights into DocuSign's insider trading patterns and financial health, access the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Atlassian (NASDAQ:TEAM) Corporation reported a strong start to fiscal year 2025, with a 31% surge in cloud revenue, exceeding the expected 27%. This growth was primarily driven by the successful integration of AI capabilities across its cloud platform and robust sales execution. Macquarie initiated coverage on Atlassian with a Neutral rating, citing a balance of upside and downside risks influencing the company's outlook.
DocuSign Inc (NASDAQ:DOCU). also reported a strong financial quarter, which led to RBC Capital Markets and Piper Sandler adjusting their outlook on the company. RBC Capital increased the price target to $90.00 from the previous $57.00 while maintaining a Sector Perform rating. Piper Sandler raised the price target to $90 from the previous $60, while maintaining a Neutral rating. The company's management drew attention to the success of its Identity Authentication Management (IAM) platform, which saw an increase in billings growth from the last quarter.
Baird and UBS also adjusted their outlook on DocuSign Inc. shares, increasing the price target to $100 from the previous $59 and $60 respectively, while maintaining a Neutral rating on the stock. The company reported a notable performance in the third fiscal quarter, with subscription revenue growth accelerating to 8% compared to 7% in the previous quarter.
These are recent developments that investors should keep an eye on.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.